MORE
A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 37 patients (estimated)
- Collaborators
- Dana-Farber Cancer Institute
- Tags
- Chemotherapy, Hypomethylating Agents (HMA), White Blood Cell Stimulant, Post-Allogeneic Stem Cell Transplant, Maintenance
- Trial Type
- Treatment
- Last Update
- SparkCures ID
- 1635
- NCT Identifier
- NCT05796570
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.